Pathogenetic insights into young-onset Parkinson disease

被引：0
作者：
Anthony H. V. Schapira
Huw R. Morris
机构：
[1] University College London Queen Square Institute of Neurology,Department of Clinical and Movement Neurosciences
来源：
Nature Reviews Neurology | 2020年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An understanding of the biochemical processes underlying Parkinson disease (PD) will be essential for the development of disease-modifying therapies. In a recent study, a novel biochemical phenotype of the disease was identified from analysis of inducible pluripotent stem cell-derived dopaminergic neurons from individuals with young-onset PD.
引用
收藏
页码：245 / 246
页数：1
相关论文
共 13 条
  • [1] Marras C(2018)Prevalence of Parkinson’s disease across North America NPJ Parkinsons Dis. 4 21-58
  • [2] Toulorge D(2016)Molecular changes in the postmortem parkinsonian brain J. Neurochem. 139 27-1529
  • [3] Schapira AHV(2012)Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease Mov. Disord. 27 1522-854
  • [4] Hajj R(2015)Genetic risk and age in Parkinson’s disease: continuum not stratum Mov. Disord. 30 850-709
  • [5] Kilarski LL(2018)Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study J. Neurol. Neurosurg. Psychiatry 89 702-299
  • [6] Nalls MA(2020)iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates Nat. Med. 26 289-1261
  • [7] Malek N(2017)Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease Science 357 1255-3203
  • [8] Laperle AH(2017)Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease Brain 140 3191-559
  • [9] Burbulla LF(2018)Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications Neuroscientist 24 540-undefined
  • [10] Robak L A(2020)Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial JAMA Neurol. undefined undefined-undefined
12